Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History $240.10 +2.33 (+0.98%) As of 03:33 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Alnylam Pharmaceuticals Stock Price Performance 5 Day Performance-2.26%1 Month Performance-1.65%3 Month Performance-1.14%6 Month Performance-16.08%Year-To-Date Performance+1.05%1 Year Performance+60.11% Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ALNY Stock Chart for Monday, April, 14, 2025 ALNY Chart by TradingViewRemove Ads Alnylam Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/11/2025$226.28$237.77+5.08%$240.00$220.541.58 million shs$30.93 billion04/10/2025$243.27$226.28-6.98%$235.33$214.761.66 million shs$29.44 billion04/09/2025$224.32$243.27+8.45%$245.56$205.872.10 million shs$31.65 billion04/09/2025$224.32$243.27+8.45%$245.56$205.872.10 million shs$31.65 billion04/08/2025$232.95$224.32-3.70%$246.15$220.421.03 million shs$29.18 billion04/08/2025$232.95$224.32-3.70%$246.15$220.421.03 million shs$29.18 billion04/07/2025$235.74$232.95-1.18%$241.83$220.001.56 million shs$30.30 billion04/04/2025$262.16$235.74-10.08%$259.16$235.571.88 million shs$30.67 billion04/03/2025$266.83$262.16-1.75%$264.65$258.651.03 million shs$34.10 billion04/02/2025$255.76$266.83+4.33%$267.29$252.07886,904 shs$34.71 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/01/2025$270.02$255.76-5.28%$273.61$255.13867,905 shs$33.27 billion03/31/2025$268.46$270.02+0.58%$271.85$258.001.07 million shs$35.13 billion03/28/2025$271.02$268.46-0.94%$271.30$264.88683,886 shs$34.75 billion03/27/2025$269.21$271.02+0.67%$276.57$264.13984,089 shs$35.09 billion03/26/2025$280.96$269.21-4.18%$281.20$268.531.07 million shs$34.85 billion03/25/2025$290.70$280.96-3.35%$292.62$280.331.07 million shs$36.37 billion03/24/2025$283.34$290.70+2.60%$300.90$287.771.77 million shs$37.63 billion03/21/2025$253.60$283.34+11.73%$289.44$261.003.15 million shs$36.68 billion03/20/2025$253.44$253.60+0.06%$261.90$252.39799,079 shs$32.83 billion03/19/2025$244.30$253.44+3.74%$255.35$243.44987,380 shs$32.81 billion03/18/2025$253.11$244.30-3.48%$263.30$243.87873,930 shs$31.63 billion03/17/2025$241.76$253.11+4.69%$253.30$240.94597,969 shs$32.77 billion03/14/2025$241.75$241.76+0.00%$244.04$239.53478,821 shs$31.30 billion03/13/2025$242.43$241.75-0.28%$245.14$239.02475,338 shs$31.38 billion Related Companies Regeneron Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Exelixis Stock Price Chart Neurocrine Biosciences Stock Price Chart Exact Sciences Stock Price Chart Halozyme Therapeutics Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredVolatility's Next Big Opportunity?With tariffs rattling the markets, many investors are watching helplessly… But according to legendary "Mark...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALNY Stock Free ALNY Stock Alerts